Home
Search

Press Releases

Get the latest on BIO's announcements, positions and views on everything from healthcare to biofuels. 

Featured Press Releases
BIO Statement on Passage of the Reconciliation…
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on passage of the One, Big, Beautiful Bill Act (OBBBA):“The OBBBA contains important bipartisan provisions…
Learn more
Massachusetts Governor Maura Healey Named BIO’s…
Annual award honors governors for their leadership and commitment to strengthening biotechnology in their state BOSTON (June 17, 2025) – Today, the Biotechnology Innovation Organization (BIO) named Massachusetts Governor Maura Healey…
Learn more
BIO Elects Genentech’s Fritz Bittenbender as New…
Industry veteran takes the helm as Dr. Ted Love concludes two-year term marked by strategic growth and transition BOSTON (June 16, 2025) – Today, the Biotechnology Innovation Organization (BIO) announced that Fritz Bittenbender,…
Learn more
All Press Releases
  • Show All
Search
Results
Event Tags
China Phase I Agreement Represents Important Step Towards Addressing Biotech Issues
January 15, 2020
Washington, D.C. (January 15, 2020) – BIO President and CEO Jim Greenwood released the following statement today regarding the signing of Phase One of the trade agreement with China: “Trade issues with China have long been a priority for BIO and…
Washington State’s Clean Fuels Program Takes to the Skies with Alaska Airlines
January 10, 2020
Today, the Sustainable Aviation Fuels (SAF) Producers Group together with the Biotechnology Innovation Organization (BIO) and the Low Carbon Fuels Coalition (LCFC) issued the following statement commending Alaska Airlines’ support for including…
USMCA Is a Missed Opportunity to Create Positive Framework for Leading Sector of 21st Century American Economy
December 19, 2019
The Biotechnology Innovation Organization (BIO) released the following statement in response to House passage of the revised USMCA: “The revised USMCA was a huge missed opportunity to create a positive framework for a dynamic and leading…
EPA’s Latest Move Adds More Uncertainty in U.S. Renewable Fuel Policy
December 19, 2019
Washington, D.C. (December 19, 2019) – The Biotechnology Innovation Organization (BIO) today released the following statement in response to EPA finalizing rules on renewable volume obligations for 2020 and SRE reallocation: “Unfortunately, this…
Importation Scheme Will Jeopardize Patient Health, Do Little to Lower Drug Costs
December 18, 2019
Washington, DC (December 18, 2019) – Following the release of the Trump administration’s drug importation proposal, BIO’s President and CEO Jim Greenwood issued the following statement: “Patients deserve access to the medicines they need with…
Salmon Labeling Provision Likely to Confuse Consumers, Impede Innovation
December 17, 2019
Washington, D.C. (December 17, 2019) – A rider to the FY2020 Agriculture Appropriations Bill will direct the bioengineered AquAdvantage salmon to carry additional labeling to distinguish it from conventionally raised Atlantic salmon. This could be…
Senate Confirms Dr. Hahn to Lead the Food and Drug Administration
December 12, 2019
Former Congressman Jim Greenwood, President and CEO of the Biotechnology Innovation Organization (BIO), issued the following statement after the U.S. Senate confirmed Dr. Stephen Hahn to serve as the next commissioner of the Food and Drug…
BIO’s Jim Greenwood on H.R. 3: “Let’s Move Past This Extreme, Partisan Bill”
December 12, 2019
Trump Administration and Speaker Pelosi Surrender Powerful Tool for Reining in Foreign Free Riding
December 10, 2019
Exclusion of biologics provisions in revised USMCA sets dangerous precedent for future trade talks, including with China Puts American jobs, intellectual property and leadership in medical innovation at risk WASHINGTON – BIO President and CEO Jim…
More than 135 Emerging Biotech Leaders Urge Congress to Reject H.R. 3
December 5, 2019
More than 135 Emerging Biotech Leaders Urge Congress to Reject H.R. 3  “Our continued success depends on maintaining an environment that supports investment in tomorrow’s discoveries.” Washington, DC: December 5, 2019 – In a letter addressed…
gooddaybio-cover-final
Daily News You Can’t Afford to Miss

Read it in under 3 minutes!

The Good Day BIO newsletter is the only daily newsletter at the intersection of biotech, politics, and policy. 

Sign Up Today